COX chemistry Flashcards

1
Q

what do you consider when treating pain?

A

–Identify source of pain
–Treat source if possible
–Provide analgesia if necessary
–Start on lowest appropriate part of pain ladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is inflammation in response to?

A

injury or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the purpose of inflammation?

A

–Treatment of inflammation: reduce the source of pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what kind of pain relief does paracetamol provide?

A

Analgesic and anti-pyretic, but not anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is paracetamols target?

A

known to act weakly on
cyclooxygenase (COX) enzymes
– Not convincing evidence for strong analgesia
• Recently discovered paracetamol metabolite
activates TRPA1 (protein on surface of nerve cells)
– Blocks transmission of pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the metabolism reactions that occur in paracetamol?

A

sulfation

glycuronidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what causes paracetamol overdose?

A

high levels of NAPQI
it is an intermediate
it is toxic and reacts with proteins in the liver and causes damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what can paracetamol be oxadised by?

A

CYP enzymes, particularly in liver

CYP3A4, CYP2E1, CYP1A2, CYP2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does NAPQI stimulate?

A

TRPA1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does the body detoxify itself in paracetamol overdose?

A

NAPQI is highly electrophilic, and is
susceptible to attack from N and S
nucleophiles.
• N-Acetylcysteine is more bioavailable than
Cys, making it a better treatment for OD.
• Sometimes methionine is used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do inflamatory disease cause inflamation?

A

– Release of leukocytes, which produce interleukin-1(IL-1)
• Potent proinflammatory cytokine
– IL-1 stimulates the action of phospholipase A2, which acts
on membrane phospholipids to release arachidonic acid
• Key precursor for the biosynthesis of prostaglandins,
thromboxanes, prostacyclin and leukotrienes
• Arachidonic acid also synthesized from dietary linoleic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which leukotrines are unstable?

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is leukotriene A converted to?

A

• Rapidly converted to other leukotrienes, e.g. Leukotrienes B, C, D, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are leukotrines C,D ad E? how do they act?

A

cysteinyl leukotrienes
– Epoxide attacked by cysteine SH
– Act on CysLT1 and CysLT2 receptors
– Cause anaphylaxis: potent hypotensives and bronchoconstrictors
– Antagonists to cysteinyl leukotriene receptors are used as prophylactics
against asthma
– e.g. Montelukast (Singulair) blocks the action of LTD4 on CysLT1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what do inhibitors of leukotriene also prove successful vs?

A

asthma eg- Zileuton (Zyflo) inhibits 5-lipoxygenase (LOX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does PGE3 cause?

A
key chemical mediator in 
inflammation
• Causes:
– Pyresis in joints and tissues
– Redness and swelling
– Pain: PGE2 acts directly on peripheral and CNS neurons, causing pain 
signal
17
Q

how is PGE2 formed?

A

Formed by action of cyclooxygenase (COX) on arachidonic
acid
– Via PGH2

18
Q

what is COX essential in?

A

essential enzyme in arachidonic acid pathway
– Biosynthesis of inflammatory mediators
– Inhibitors active as anti-inflammatory agents
•  Non-steroidal anti-inflammatory drugs (NSAIDs)

19
Q

how do steroids produce their anti-inflammatory action?

A

Glucocorticoid steroids, such as dexamethasone, activate lipocortin,
which inhibits phospholipase A2 and prevents the formation of
arachidonic acid

20
Q

what are the classes of NSAIDS

A

Salicylates, aryl- and heteroaryl-alkanoic acids, oxicams,

anthranilic acids, pyranocarboxylic acids, plus prodrugs

21
Q

what is the only non-reversible COX inhibitor?

A

aspirin

22
Q

what does sulindac undergo?

A

redox transformation

reduces it to thioether

23
Q

how is the prodrug of sulindac reactivated?

A

through an oxidoreductase enzyme

24
Q

what is the pka of piroxicam?

A

4.6

25
Q

how do NSAIDs work?

A

all NSAIDs inhibit COX - except aspirin

reduces fomration of pge2

26
Q

what are the result of NSAID?

A

– anti-inflammatory (reducing source of pain)
– analgesic (block signalling of pain)
– anti-pyretic (reduce temperature rise – pyresis – associated with
inflammation)

27
Q

what is aspirin synthesised from?

A

willow bark

28
Q

how does aspirin work?

A

Acetyl salicylate more palatable and less damaging to oral

and GI tissues and acetyl gives potent COX inhibition

29
Q

why is aspirin irreversible?

A

• Irreversible COX inhibition through acetylation of serine in
active site
– Also suppresses formation of TXA2 by inhibiting COX in platelets
– TXA2 induces platelet aggregation
– Hence aspirin leads to inhibition of platelet aggregation
– Risk of myocardial infarction reduced significantly

30
Q

what is the difference in the two isoforms of COX enzymes?

A

COX-1 (constitutive)
– Present in most tissues all the time
– Induces platelet aggregation
– Produces PGs that protect gastric mucosa
– Appears linked to normal cellular activity: homeostasis?
• COX-2 (inducible)
– Present in brain and kidney normally (constitutive)
– Induced by cytokines (inflammation) and injury in most tissues
– Produces PGs that inhibit platelet aggregation and cause pain/swelling
– Part of inflammatory response

31
Q

what is produced by cox 2?

A

Prostacyclin (PGI2)
– Vasodilator
– Produced by endothelial cells
– Inhibits platelet aggregation

32
Q

what is produced by COX 1

A

• Thromboxane A2
– Vasoconstrictor
– Produced by platelets
– Induces platelet aggregation